Cost-effectiveness of folic acid therapy for primary prevention of stroke in patients with hypertension https://t.co/zY7XDYMBUo https://t.co/cr4tJMRnI3 @mheduNIMHANS @ICMRDELHI @NMC_IND @WHO @NIH @Innov_Medicine https://t.co/gQciHHlRdz
RT @BMCMedicine: Tiantian Zhang and colleagues report that Folic acid is an affordable and beneficial treatment strategy which reduces the…
Tiantian Zhang and colleagues report that Folic acid is an affordable and beneficial treatment strategy which reduces the risk of primary stroke when combined with enalapril compared to enalapril monotherapy. Read the full story here: https://t.co/k8jjbdk
Cost-effectiveness of folic acid therapy for primary prevention of stroke in patients with hypertension https://t.co/zY7XDZ3EWo -> Adding #folic acid to enalapril may be a cost-effective strategy for the prevention of primary stroke in hypertensive pat